MedTrace Logo

Swift, Certain, and Fair: Reducing Recidivism and Improving Outcomes for Alcohol and Drug Users on State Parole

NCT03826420 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 250

Last updated 2019-03-11

No results posted yet for this study

Summary

This research project will study the outcomes of medium- to high-risk parolees with a history of substance abuse in Alleghany County, Pennsylvania supervised under Swift-Certain-Fair parole.

The research goals are to:

* Determine the effectiveness of SCF parole in reducing recidivism among medium- to high-risk parolees with a history of substance abuse in Pennsylvania.
* Determine the minimum effective sanction in response to a violation that will bring parolees into compliance with the conditions of their parole.

Conditions

Interventions

BEHAVIORAL

SCF Supervision with Secure Confinement Sanctioning

Parolees assigned to this group will, in the face of a violation, be given a sanction that involves secure confinement.

BEHAVIORAL

SCF Supervision with Work Release Sanctioning

Parolees assigned to this group will, in the face of a violation, be given a sanction that involves work-release.

BEHAVIORAL

SCF Supervision with GPS Supervision Sanctioning

Parolees assigned to this group will, in the face of a violation, be given a sanction that involves GPS supervision.

Sponsors & Collaborators

  • Pennsylvania Department of Corrections

    collaborator UNKNOWN

  • Bureau of Justice Assistance

    collaborator UNKNOWN

  • Botec Analysis, LLC

    lead INDUSTRY

Principal Investigators

  • Mark AR Kleiman · BOTEC Analysis

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-04-01
Primary Completion
2020-08-15
Completion
2020-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03826420 on ClinicalTrials.gov